XtalPi Inc. Unveils "XtalPi Intelligent Automation" and Announces New Automation Facility in Shanghai

XtalPi Inc. a prominent technology platform company known for its unique fusion of physics-based computation, artificial intelligence (AI), and robotics to drive the advancement of groundbreaking pharmaceuticals and innovative materials, has unveiled its latest brand, XtalPi Intelligent Automation. The introduction took place at the inaugural Intelligent Automation Forum on August 25th, 2023, in Shanghai, China.

The inception of XtalPi Intelligent Automation embodies the overarching vision of XtalPi to redefine contemporary laboratory automation solutions, fundamentally reshaping the landscape of scientific exploration and effectively addressing substantial challenges in research and development across diverse industries. This brand serves as the driving force behind the creation and deployment of cutting-edge laboratory automation platforms designed to enhance efficiency, flexibility, scalability, and the seamless integration of third-party hardware and software. It also emphasizes the application of digital twin technologies. Through this brand, a wide array of discovery services and solutions powered by these platforms are offered to global partners.

During the forum, XtalPi additionally disclosed the inauguration of a novel facility in Shanghai, a strategic maneuver aimed at expanding its capabilities to meet the swiftly escalating demand for top-tier, efficient R&D outsourcing across various domains, including drug and materials discovery. Positioned as XtalPi's most extensive automation lab in China, this Shanghai establishment surpasses the automation R&D lab at the company's headquarters in Shenzhen. The facility is scheduled to become fully operational by the latter part of Q3 2023, accommodating more than 100 automated workstations and automation clusters. Initial focal points will center on providing services for drug discovery and pharmaceutical development initiatives. With sites in Shenzhen, Shanghai, and Boston, XtalPi now operates three global automation laboratories to cater to partners across key hubs.

Jian Ma, CEO of XtalPi, remarked, "Our unwavering dedication lies in establishing a robust, intelligent R&D infrastructure, crafting tools tailored for optimal data flow, and leading the way in the realm of next-generation automated laboratory systems." Ma continued, "Our infrastructure is intricately designed to harness the immense potential of big data. These data are harnessed by AI to yield insights and concepts that guide and accelerate R&D processes. Our diverse portfolio, spanning from individual automated workstations to expansive cluster automation and specialized chemical synthesis services for drug discovery, is a testament to our commitment to revolutionizing the landscape of scientific practices in the times ahead."

Source:prnewswire.com